Cargando…

Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?

Objective In this study, we aimed at comparing the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in healthcare workers (HCWs) in coronavirus disease 2019 (COVID-19) receiving and non-COVID-19 receiving hospitals in Peshawar, Pakistan. Methods This cross-se...

Descripción completa

Detalles Bibliográficos
Autores principales: Noor, Mohammad, Haq, Mohsina, Ul Haq, Najib, Amin, Said, Rahim, Fawad, Bahadur, Sher, Ullah, Raza, Khan, Muhammad Asif, Mahmood, Afsheen, Gul, Huma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654561/
https://www.ncbi.nlm.nih.gov/pubmed/33194502
http://dx.doi.org/10.7759/cureus.11389
_version_ 1783608092143910912
author Noor, Mohammad
Haq, Mohsina
Ul Haq, Najib
Amin, Said
Rahim, Fawad
Bahadur, Sher
Ullah, Raza
Khan, Muhammad Asif
Mahmood, Afsheen
Gul, Huma
author_facet Noor, Mohammad
Haq, Mohsina
Ul Haq, Najib
Amin, Said
Rahim, Fawad
Bahadur, Sher
Ullah, Raza
Khan, Muhammad Asif
Mahmood, Afsheen
Gul, Huma
author_sort Noor, Mohammad
collection PubMed
description Objective In this study, we aimed at comparing the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in healthcare workers (HCWs) in coronavirus disease 2019 (COVID-19) receiving and non-COVID-19 receiving hospitals in Peshawar, Pakistan. Methods This cross-sectional analytical study was conducted in a COVID-19 receiving hospital (hospital ‘A’) and a non-COVID-19 receiving hospital (hospital ‘B’). Using stratified random sampling, 1,011 HCWs (439 from hospital ‘A’ and 572 from hospital ‘B’) were recruited to participate in the study. Immunoglobulin G/immunoglobulin M (IgG/IgM) antibodies were checked using Elecsys® (Roche, Basel, Switzerland) Anti-SARS-CoV-2 immunoassay. The chi-squared test was used to compare frequencies, and the binary logistic regression model was used to predict the association between study variables' seropositivity to SARS-CoV-2. A p-value of <0.05 was considered statistically significant. Results The overall seroprevalence to SARS-CoV-2 antibodies in the two hospitals was 30.76%. It was 28.2% in hospital ‘A’ and 32.7% in hospital ‘B’ (p=0.129). The seroprevalence in HCWs having direct contact with COVID-19 patients was higher (33.1%) in non-COVID-19 receiving hospital versus 23.8% in COVID-19 receiving hospital (p=0.034). Seroprevalence was highest among administrative staff (44.0%), followed by nurses (30.8%), residents (19.8%), and consultants (17.8%) (p=0.001). As compared to consultants, the administrative and nursing staff were 3.398 and 3.116 times more likely to have positive antibodies, respectively. There were no significant differences in the seroprevalence between the respective categories of staff of the two hospitals. Conclusions The non-COVID-19 receiving hospital had a higher proportion of seropositive HCWs than the COVID-19 receiving hospital. The HCWs in the non-COVID-19 receiving hospital who had direct contact with patients had significantly higher seroprevalence. Seroprevalence was highest for administrative staff followed by nursing staff, residents, and consultants. Regardless of the COVID-19 status of the healthcare facility, all HCWs shall be trained on, and consistently follow, the proper protocols for donning and doffing of personal protective equipment (PPE).
format Online
Article
Text
id pubmed-7654561
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-76545612020-11-12 Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2? Noor, Mohammad Haq, Mohsina Ul Haq, Najib Amin, Said Rahim, Fawad Bahadur, Sher Ullah, Raza Khan, Muhammad Asif Mahmood, Afsheen Gul, Huma Cureus Preventive Medicine Objective In this study, we aimed at comparing the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in healthcare workers (HCWs) in coronavirus disease 2019 (COVID-19) receiving and non-COVID-19 receiving hospitals in Peshawar, Pakistan. Methods This cross-sectional analytical study was conducted in a COVID-19 receiving hospital (hospital ‘A’) and a non-COVID-19 receiving hospital (hospital ‘B’). Using stratified random sampling, 1,011 HCWs (439 from hospital ‘A’ and 572 from hospital ‘B’) were recruited to participate in the study. Immunoglobulin G/immunoglobulin M (IgG/IgM) antibodies were checked using Elecsys® (Roche, Basel, Switzerland) Anti-SARS-CoV-2 immunoassay. The chi-squared test was used to compare frequencies, and the binary logistic regression model was used to predict the association between study variables' seropositivity to SARS-CoV-2. A p-value of <0.05 was considered statistically significant. Results The overall seroprevalence to SARS-CoV-2 antibodies in the two hospitals was 30.76%. It was 28.2% in hospital ‘A’ and 32.7% in hospital ‘B’ (p=0.129). The seroprevalence in HCWs having direct contact with COVID-19 patients was higher (33.1%) in non-COVID-19 receiving hospital versus 23.8% in COVID-19 receiving hospital (p=0.034). Seroprevalence was highest among administrative staff (44.0%), followed by nurses (30.8%), residents (19.8%), and consultants (17.8%) (p=0.001). As compared to consultants, the administrative and nursing staff were 3.398 and 3.116 times more likely to have positive antibodies, respectively. There were no significant differences in the seroprevalence between the respective categories of staff of the two hospitals. Conclusions The non-COVID-19 receiving hospital had a higher proportion of seropositive HCWs than the COVID-19 receiving hospital. The HCWs in the non-COVID-19 receiving hospital who had direct contact with patients had significantly higher seroprevalence. Seroprevalence was highest for administrative staff followed by nursing staff, residents, and consultants. Regardless of the COVID-19 status of the healthcare facility, all HCWs shall be trained on, and consistently follow, the proper protocols for donning and doffing of personal protective equipment (PPE). Cureus 2020-11-09 /pmc/articles/PMC7654561/ /pubmed/33194502 http://dx.doi.org/10.7759/cureus.11389 Text en Copyright © 2020, Noor et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Preventive Medicine
Noor, Mohammad
Haq, Mohsina
Ul Haq, Najib
Amin, Said
Rahim, Fawad
Bahadur, Sher
Ullah, Raza
Khan, Muhammad Asif
Mahmood, Afsheen
Gul, Huma
Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?
title Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?
title_full Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?
title_fullStr Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?
title_full_unstemmed Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?
title_short Does Working in a COVID-19 Receiving Health Facility Influence Seroprevalence to SARS-CoV-2?
title_sort does working in a covid-19 receiving health facility influence seroprevalence to sars-cov-2?
topic Preventive Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654561/
https://www.ncbi.nlm.nih.gov/pubmed/33194502
http://dx.doi.org/10.7759/cureus.11389
work_keys_str_mv AT noormohammad doesworkinginacovid19receivinghealthfacilityinfluenceseroprevalencetosarscov2
AT haqmohsina doesworkinginacovid19receivinghealthfacilityinfluenceseroprevalencetosarscov2
AT ulhaqnajib doesworkinginacovid19receivinghealthfacilityinfluenceseroprevalencetosarscov2
AT aminsaid doesworkinginacovid19receivinghealthfacilityinfluenceseroprevalencetosarscov2
AT rahimfawad doesworkinginacovid19receivinghealthfacilityinfluenceseroprevalencetosarscov2
AT bahadursher doesworkinginacovid19receivinghealthfacilityinfluenceseroprevalencetosarscov2
AT ullahraza doesworkinginacovid19receivinghealthfacilityinfluenceseroprevalencetosarscov2
AT khanmuhammadasif doesworkinginacovid19receivinghealthfacilityinfluenceseroprevalencetosarscov2
AT mahmoodafsheen doesworkinginacovid19receivinghealthfacilityinfluenceseroprevalencetosarscov2
AT gulhuma doesworkinginacovid19receivinghealthfacilityinfluenceseroprevalencetosarscov2